HOME >> BIOLOGY >> NEWS
Dr. Thomas Starzl receiving prestigious King Faisal International prize this week in Saudi Arabia

Transplant pioneer Thomas E. Starzl, M.D., Ph.D., professor of surgery at the University of Pittsburgh School of Medicine, will accept one of the world's most prestigious awards, the King Faisal International Prize for Medicine, at a formal ceremony to be held Feb. 17 in Riyadh, Saudi Arabia, under the auspices of the King of Saudi Arabia.

According to the King Faisal Foundation, the largest philanthropic organization in the Middle East, the prize is in recognition of Dr. Starzl's outstanding contributions in the field of organ transplantation. He shares the award with two other transplant pioneers, Norman E. Shumway, M.D., a heart transplant surgeon from Stanford University, and Sir Roy Calne, a liver transplant surgeon from the University of Cambridge, United Kingdom. Each will receive a uniquely cast, commemorative 24-carat, 200-gram gold medal. The award's cash endowment of $200,000 will be divided among the three winners.

"Professor Starzl's pioneering work has influenced all aspects of organ transplantation," said officials from the Faisal Foundation when the winners of the prizes were announced in December.

Dr. Starzl performed the world's first liver transplant in 1963 at the University of Colorado. In 1962 and 1963, he introduced the concept of incorporating corticosteroids into the immunosuppression regimen for patients receiving kidney transplants from non-identical human living donors, which led to the largest series of kidney transplants and invigorated clinical attempts throughout the world. Lessons learned from kidney transplantation and other discoveries he made about liver physiology resulted in his performing the world's first successful liver transplant in 1967.

Since coming to the University of Pittsburgh in 1981, Dr. Starzl pioneered the immunosuppressive agent tacrolimus, resulting in significant improvements in organ transplant survival rates and allowing successful transplantation of the small intestine and multivisceral graf
'"/>

Contact: Lisa Rossi
rossil@msx.upmc.edu
412-647-3555
University of Pittsburgh Medical Center
11-Feb-2001


Page: 1 2 3

Related biology news :

1. UCRs Thomas Miller awarded prestigious medal from Academy of Sciences of the Czech Republic
2. Gene expression ratio identifies risk of recurrence in breast cancer patients receiving tamoxifen
3. DuPont part of science-based consortium receiving U.S. Dept. of Energy Bio-Refinery grant
4. Research shows different races, ethic groups receiving different levels of preventive care
5. Jefferson researchers find access to new methods of HIV prevention for pregnant women and newborns may depend on where they were receiving care
6. Gladstone investigator Mike McCune wins prestigious NIH Directors Pioneer Award
7. Carnegie Mellon computational biologist Russell Schwartz receives prestigious CAREER award
8. Brown earns prestigious geography award
9. Ohio State wetlands professor wins prestigious Water Prize
10. Top US scientist honored with prestigious award
11. Dr. Walter Reich, Ph.D., receives prestigious AAAS 2003 Scientific Freedom and Responsibility Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2016)... 20, 2016  Synaptics Incorporated (NASDAQ: SYNA ... today announced sampling of S1423, its newest ClearPad ... small screen applications including smartwatches, fitness trackers, and ... and rectangular shapes, as well as thick and ... moisture on screen, while wearing gloves, and supports ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
(Date:1/7/2016)... Jan. 7, 2016 Various factors have ... products such as biologics and biosimilars. Some of ... healthcare expenditure, growing demand for cost-effective alternatives, growing ... Biosimilars are similar versions of their corresponding patented ... their quality, safety, and efficacy. The global biosimilars ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical ... for a host of launch activities including the identification ... this launch activity is especially high in the oncology ... Best Practices and the Role of Medical Affairs ... companies focused on oncology therapies find better ways to ...
(Date:2/4/2016)... CA (PRWEB) , ... February 04, 2016 , ... ... enterprise talent development and compliance training, today announced an interactive FDA compliance ... Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course on Morf ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... Club, takes place February 5-6 at the University’s student center, Kehr Union, ... such as workshops and competitions for ample networking, learning and collaborating opportunities. ...
(Date:2/4/2016)... -- --> --> Q ... to provide the following update on recent corporate developments. ... 3 months we have significantly increased our cash position through ... a result, we have positioned ourselves to execute on the ... expect that development to continue on schedule. ...
Breaking Biology Technology:
Cached News: